HER2 Immunohistochemistry-Guided Targeted Fluorescence In Situ Hybridization Analysis Does Not Help Identify Intratumoral Heterogeneity in Breast Cancer.

HER2 Immunohistochemistry-Guided Targeted Fluorescence In Situ Hybridization Analysis Does Not Help Identify Intratumoral Heterogeneity in Breast Cancer.

Arch Pathol Lab Med. 2016 Aug;140(8):741

Authors: Gulbahce HE, Factor R, Geiersbach K, Downs-Kelly E

PMID: 27472230 [PubMed - as supplied by publisher]

http://ift.tt/2aCcT0q

http://ift.tt/2ao0qwR


from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2ah6Egi
via IFTTT